Gb Sciences Stock Fundamentals
| GBLX Stock | USD 0.01 0 38.46% |
GB Sciences fundamentals help investors to digest information that contributes to GB Sciences' financial success or failures. It also enables traders to predict the movement of GBLX Pink Sheet. The fundamental analysis module provides a way to measure GB Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GB Sciences pink sheet.
GBLX |
GB Sciences Company Current Valuation Analysis
GB Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GB Sciences Current Valuation | 10.19 M |
Most of GB Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GB Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GB Sciences has a Current Valuation of 10.19 M. This is 99.93% lower than that of the Healthcare sector and 99.78% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
GB Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GB Sciences's current stock value. Our valuation model uses many indicators to compare GB Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GB Sciences competition to find correlations between indicators driving GB Sciences's intrinsic value. More Info.GB Sciences is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value GB Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GB Sciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.GBLX Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GB Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GB Sciences could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics of similar companies.GB Sciences is currently under evaluation in current valuation category among its peers.
GBLX Fundamentals
| Return On Equity | -50.98 | |||
| Return On Asset | -0.21 | |||
| Current Valuation | 10.19 M | |||
| Shares Outstanding | 379.21 M | |||
| Shares Owned By Insiders | 13.08 % | |||
| Price To Earning | 4.04 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 1.91 X | |||
| Gross Profit | (881.46 K) | |||
| EBITDA | 398.73 K | |||
| Net Income | (530.87 K) | |||
| Cash And Equivalents | 53.96 K | |||
| Total Debt | 397.31 K | |||
| Debt To Equity | 1.07 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.87 M) | |||
| Beta | 0.56 | |||
| Market Capitalization | 8.21 M | |||
| Total Asset | 2.55 M | |||
| Retained Earnings | (78.28 M) | |||
| Working Capital | 881 K | |||
| Current Asset | 2.2 M | |||
| Current Liabilities | 1.32 M | |||
| Z Score | -30.0 | |||
| Net Asset | 2.55 M |
About GB Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GB Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GB Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GB Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GBLX Pink Sheet Analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.